Published in Science on September 09, 1988
A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol (1991) 3.13
Retracted Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A (1989) 1.59
A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol (2008) 1.58
Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest (1992) 1.55
Secretion without Golgi. J Cell Biochem (2008) 1.39
Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc Natl Acad Sci U S A (1993) 1.36
Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol (1990) 1.31
Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol (1990) 1.28
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity. Br J Cancer (1992) 0.99
Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. Am J Pathol (1997) 0.98
Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med (2009) 0.95
Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng (2014) 0.93
Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications. Int J Nanomedicine (2013) 0.90
VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg (2007) 0.89
Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. Tex Heart Inst J (2000) 0.86
DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. Nat Commun (2012) 0.85
Improved airway healing using basic fibroblast growth factor in a canine tracheal autotransplantation model. Ann Surg (1998) 0.82
Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res (2014) 0.80
Regulation of non-classical FGF1 release and FGF-dependent cell transformation by CBF1-mediated notch signaling. J Cell Physiol (2011) 0.80
FGF2-adsorbed macroporous hydroxyapatite bone granules stimulate in vitro osteoblastic gene expression and differentiation. J Mater Sci Mater Med (2010) 0.79
Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells. PLoS One (2014) 0.76
Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization. Tex Heart Inst J (2009) 0.76
Engineered collagen hydrogels for the sustained release of biomolecules and imaging agents: promoting the growth of human gingival cells. Int J Nanomedicine (2014) 0.75
Effect of internal viral sequences on the utility of retroviral vectors. J Virol (1987) 6.06
The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem (1989) 5.98
Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24
The molecular basis of lung morphogenesis. Mech Dev (2000) 4.87
Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science (1985) 4.77
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
Multiple sequence alignment. J Mol Biol (1986) 4.27
An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci U S A (1979) 4.26
Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science (1986) 4.17
Serial propagation of human endothelial cells in vitro. J Cell Biol (1981) 4.04
Prospects for human gene therapy. Science (1984) 3.93
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
DNA-binding proteins. Science (1983) 3.56
The molecular basis of DNA-protein recognition inferred from the structure of cro repressor. Nature (1982) 3.56
Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem (1990) 3.02
Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science (1984) 3.00
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Structural similarity in the DNA-binding domains of catabolite gene activator and cro repressor proteins. Proc Natl Acad Sci U S A (1982) 2.84
The regulation of initiation of mammalian protein synthesis. Prog Nucleic Acid Res Mol Biol (1981) 2.81
Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78
A mouse model for beta-thalassemia. Cell (1983) 2.70
Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68
An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem (1990) 2.65
Isolation and partial characterization of reticulocyte factors M1 and M2. J Biol Chem (1970) 2.59
Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science (1990) 2.59
Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 11qter. Proc Natl Acad Sci U S A (1981) 2.50
Human gene therapy. Annu Rev Biochem (1993) 2.49
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A (1989) 2.48
Residues that mediate DNA binding of autoimmune antibodies. J Immunol (1993) 2.37
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature (1970) 2.27
Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J Virol (1992) 2.25
Cell-free hemoglobin synthesis. II. Characteristics of the transfer ribonucleic acid-dependent assay system. J Biol Chem (1970) 2.24
Covalent structure of a group-specific protease from rat small intestine. Appendix: crystallographic data for a group specific protease from rat intestine. Biochemistry (1978) 2.17
Organizational behavior of human umbilical vein endothelial cells. J Cell Biol (1982) 2.15
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol (1993) 2.12
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol (1996) 2.12
Replication and expression of thymidine kinase and human globin genes microinjected into mouse fibroblasts. Proc Natl Acad Sci U S A (1980) 2.10
Structure of the DNA-binding region of lac repressor inferred from its homology with cro repressor. Proc Natl Acad Sci U S A (1982) 2.09
Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem (1994) 2.07
In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest (1992) 2.04
Cloning and characterization of DNA sequences surrounding the human gamma-, delta-, and beta-globin genes. Proc Natl Acad Sci U S A (1980) 2.04
Translation of exogenous messenger RNA for hemoglobin on reticulocyte and liver ribosomes. Proc Natl Acad Sci U S A (1971) 2.03
Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther (1994) 1.95
Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med (1990) 1.89
Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol (1989) 1.86
Kinetic studies on Cro repressor-operator DNA interaction. J Mol Biol (1987) 1.85
Purification and physical properties of homogeneous initiation factor MP from rabbit reticulocytes. J Biol Chem (1975) 1.83
Seeding of intravascular stents with genetically engineered endothelial cells. Circulation (1989) 1.82
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol (1995) 1.82
Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science (1990) 1.81
Many gene-regulatory proteins appear to have a similar alpha-helical fold that binds DNA and evolved from a common precursor. J Mol Evol (1983) 1.80
Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc Natl Acad Sci U S A (1985) 1.79
Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci U S A (2001) 1.79
Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J (1995) 1.76
Translation of rabbit haemoglobin messenger RNA by thalassaemic and non-thalassaemic ribosomes. Nat New Biol (1971) 1.75
Isolation and translation of hemoglobin messenger RNA from thalassemia, sickle cell anemia, and normal human reticulocytes. J Clin Invest (1971) 1.74
Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol (1987) 1.72
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1986) 1.70
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol (1994) 1.69
Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation. Proc Natl Acad Sci U S A (1975) 1.68
Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res (1992) 1.66
Recruitment behavior and program directors: how ethical are their perspectives about the match process? Fam Med (2000) 1.64
Human gene therapy protocols: RAC review. Science (1995) 1.64
High and low molecular weight forms of endothelial cell growth factor. J Biol Chem (1982) 1.63
Nucleotide sequence of the dmsABC operon encoding the anaerobic dimethylsulphoxide reductase of Escherichia coli. Mol Microbiol (1988) 1.63
Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods (1989) 1.63
Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol (2001) 1.61
Bovine fibroblast growth factor: comparison of brain and pituitary preparations. J Cell Biol (1982) 1.61
Prospects for in utero human gene therapy. Science (1999) 1.61
Structural and functional homology of parvovirus and papovavirus polypeptides. J Gen Virol (1987) 1.59
Retracted Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A (1989) 1.59
Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci U S A (1987) 1.58
Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization. J Biol Chem (1985) 1.58
Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature (1993) 1.58
Selective activation of human beta-but not gamma-globin gene in human fibroblast x mouse erythroleukaemia cell hybrids. Nature (1979) 1.58
Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol (1993) 1.58
Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol (1985) 1.56
International symposium on protein synthesis. Summary of Fogarty Center-NIH Workshop held in Bethesda, Maryland on 18-20 October, 1976. FEBS Lett (1977) 1.55
Cell-free transcription of mammalian chromatin: transcription of globin messenger RNA sequences from bone-marrow chromatin with mammalian RNA polymerase. Proc Natl Acad Sci U S A (1974) 1.54
Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg (1994) 1.54
Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development (1995) 1.53
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet (1993) 1.53
Modulation of the sis gene transcript during endothelial cell differentiation in vitro. Science (1985) 1.53
Nucleotide sequence and gene-polypeptide relationships of the glpABC operon encoding the anaerobic sn-glycerol-3-phosphate dehydrogenase of Escherichia coli K-12. J Bacteriol (1988) 1.53
Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer (2001) 1.52
Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J Biol Chem (1993) 1.51
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 1.51
Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy? Ophthalmology (1995) 1.50
Comparison of the structures of cro and lambda repressor proteins from bacteriophage lambda. J Mol Biol (1983) 1.48
Differential activation of the mouse beta-globin promoter by enhancers. Mol Cell Biol (1983) 1.47
Relation between hen egg white lysozyme and bacteriophage T4 lysozyme: evolutionary implications. J Mol Biol (1981) 1.46
The urology residency matching program in practice. J Urol (2000) 1.46
An angiogenic growth factor is expressed in human glioma cells. EMBO J (1987) 1.46